LearnSkin

IDCP

Week 21: Autoimmune, Autoinflammatory, and Pediatrics

5 Lessons
523 Enrolled

Course Overview

Preview what you'll learn in this program

Oct 2020
Released
Feb 2021
Expires
91% avg
Completion

What You'll Learn

Target Audience

This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients.

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and LearnHealth. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

SynAptiv designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The content in this program may qualify for pain management credit. Please check with your State Board for proper certification.

Disclosure of Conflicts of Interest

SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by SynAptiv to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SynAptiv is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of FacultyReported Financial Relationship

Apple Bodemer, MD

No financial relationships to disclose

Michelle Jeffries, DO

No financial relationships to disclose

Peter Lio, MD

Consulting Fees/Advisory Board. Grants/Research Support. Speakers Bureau. National Eczema Association, Modernizing Medicine, Johnson & Johnson Consumer Products, DermTap, Inc., Pierre Fabre Dermatologie, La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis), Valeant Pharmaceuticals International, IntraDerm Pharmaceuticals, Valeant Pharmaceuticals North America LLC, Regeneron, Sanofi US Services, Exeltis, AOBiome LLC, Theraplex, Odeza LLC, Realm Therapeutics, Pfizer Inc., La Roche-Posay Laboratorie Pharmaceutique, L’Oreal USA Inc., Menlo Therapeutics, Franklin BioScience, AbbVie, Syncere Skin Systems, Kiniksa Pharmaceuticals Ltd., Eli Lilly and Company, Unilever, gpower, inc., UCB, Altus Labs, Dermavant Sciences, Micreos Human Health B.V.-, Dermira, LearnHealth/LearnSkin, AbbVie, Medable, Verrica Pharmaceuticals Inc, TopMD, Amyris, Inc., LEO Laboratories Ltd (LEO Pharma)

Raja Sivamani, MD MS AP

Consulting Fees. Burt’s Bees and Dermala; Medical Editor at LearnHealth Inc.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content ManagerReported Financial Relationship

Venita Sivamani, Planner

LearnHealth founder and shareholder

Planners at SynAptiv

No financial relationships to disclose

All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved 

Method Participation

Participants must 1) read the program information, 2) study the educational activity, 3) complete the posttest by recording the best answer to each quiz question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Statements of credit will be available once the midterm and final exams are completed and evaluation forms submitted.

Media

Internet

Disclaimer

The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of SynAptiv and/or LearnHealth. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see the policy at yourcesource.com/privacy.htm.

Contact Information

This activity is jointly provided by SynAptiv and LearnHealth.

Questions about CE accreditation or CE certificates related to this course, please contact us via email at [email protected]. For all other questions, please contact [email protected].

Accreditation Information

Welcome to week 21 as we take a look at new treatments for autoimmune, autoinflammatory, and pediatric dermatology!

Autoimmune and Autoinflammatory Conditions: Update on Pathophysiology

This activity covers the basic pathophysiology of autoimmune and autoinflammatory conditions. T cell subsets and the Aryl Hydrocarbon receptor activity were shown to modulate with food and herbal intake. The use of botanicals will be assessed in the context of the mTOR pathway.

After completing this activity, participants will be able to:

  1. Diagram the role of Aryl Hydrocarbon receptors in modulating autoimmunity and inflammation
  2. Recall the subsets of Th cells and the role of Treg cells in modulating autoimmunity and inflammation
  3. Evaluate the evidence for the role of herbs and foods in modulating aryl hydrocarbon receptor activation and Treg proliferation

Pediatric Skin Infections

This activity covers the basic clinical presentations of common and uncommon skin infections in the pediatric population. There is also emphasis on important must-not-miss mimics.

After completing this activity, participants will be able to:

  1. Describe the current guidelines for pediatric skin infections
  2. Outline some of the potential therapies that may be used
  3. Identify some of the pitfalls and limitations of these approaches

Lichen Planus

This session will review the clinical presentation of lichen planus and both integrative and pharmaceutical approaches to treatment.

After completing this activity, participants will be able to:

  1. Review the environmental risk factors for lichen planus
  2. Evaluate the evidence for the use of curcumin for lichen planus

Autoimmune Blistering Disorders

This course will review the different types of autoimmune blistering diseases and discuss integrative approaches to managing autoimmune blistering disorders.

After completing this activity, participants will be able to:

  1. Differentiate autoimmune blistering conditions
  2. Explain the role diet plays in the development of autoimmune diseases
  3. Identify herbs that should be avoided by patients with autoimmune disease

Integrative Treatment of Warts & Molluscum in Pediatric Patients

This lecture will review the treatment options for managing verruca and molluscum from an integrative perspective. Topics covered will include conventional and non-conventional approaches.

After completing this activity, participants will be able to:

  1. Review diagnostic qualities of non-genital verruca vulgaris & molluscum contagiosum in immunocompetent pediatric patients
  2. Discuss treatment modalities for verruca vulgaris & molluscum contagiosum •In-office treatments •Prescription treatments
    • At-home remedies

✨ Ready to Begin Your Journey? ✨

Enroll now to start the course and unlock all learning materials

Login
Lesson 10hr 22min

Autoimmune and Autoinflammatory Conditions: Update on Pathophysiology

Complete the previous section to unlock this lesson

Lesson 20hr 24min

Pediatric Skin Infections

Complete the previous section to unlock this lesson

Lesson 30hr 16min

Lichen Planus

Complete the previous section to unlock this lesson

Lesson 40hr 30min

Autoimmune Blistering Disorders

Complete the previous section to unlock this lesson

Lesson 51hr 8min

Integrative Treatment of Warts & Molluscum in Pediatric Patients

Complete the previous section to unlock this lesson

Post-Quiz

Asess your learning and review your progress

Questions
0
Passing Score
70%
Average Score
91%

Course Discussion

Join the conversation with fellow learners

Continue Your Learning Journey

Next course in IDCP

Course: Week 23: Update on Pathophysiology of Hair Health
Next in Series
Course in series

Week 23: Update on Pathophysiology of Hair Health

Week 23: Update on Pathophysiology of Hair Health

Non-CME
Start Next Course
LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2026.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!